| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±4.3% | -4.1% | over-priced |
| 05/08/2026 | ±3.6% | -9.0% | under-priced |
| 02/13/2026 | ±6.2% | -6.4% | under-priced |
| 11/07/2025 | ±3.5% | +17.6% | under-priced |
| 08/08/2025 | ±3.2% | +4.1% | under-priced |
| 05/09/2025 | ±3.3% | -7.3% | under-priced |
| 02/07/2025 | ±2.6% | +17.3% | under-priced |
| 11/08/2024 | ±2.9% | +3.8% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $7.16 | $4.3B | $878M |
| Q1 FY2026 | $-0.05 | $3.4B | $-6M |
| Q4 FY2025 | — | $3.5B | $205M |
| Q3 FY2025 | $7.33 | $4.4B | $959M |
EXPE (EXPE) reports in 8 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±3.7% earnings move while the stock actually moved 8.7% on average — the market has tended to under-price EXPE's earnings risk. Fundamentals into the print: EPS up 188.7% year-over-year, revenue up 14.0%. QuantLogix's live 5-factor engine currently reads EXPE as a buy at 67/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →